S-B. Kim
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 16
- Cancer Immunotherapy and Biomarkers 8
-
- Advanced Breast Cancer Therapies 15
- Co-authors
- Hee Jung Shin (1 shared paper)Kyung Hae Jung (4 shared papers)Seong Hee Ahn (1 shared paper)Seock‐Ah Im (10 shared papers)Takashi Kojima (2 shared papers)Pooja Bhagia (2 shared papers)Peter C. Enzinger (2 shared papers)Jillian M. Cathcart (3 shared papers)
- Journals
- Annals of Oncology (29 papers)ESMO Open (9 papers)Cancer Research (5 papers)Diseases of Aquatic Organisms (1 paper)British Journal of Radiology (1 paper)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
S-B. Kim
50 papers receiving 839 citations
Peers
Comparison fields: 5 of 43
- Oncology 301
- Cancer Research 135
- Pulmonary and Respiratory Medicine 259
- Otorhinolaryngology 28
- Radiology, Nuclear Medicine and Imaging 80
Countries citing papers authored by S-B. Kim
This map shows the geographic impact of S-B. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S-B. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S-B. Kim more than expected).
Fields of papers citing papers by S-B. Kim
This network shows the impact of papers produced by S-B. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S-B. Kim. The network helps show where S-B. Kim may publish in the future.
Co-authors
The 25 scholars most cited alongside S-B. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 111 | |
| 2 | 2019 | 100 | |
| 3 | 2011 | 93 | |
| 4 | 2021 | 81 | |
| 5 | Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus. The Phase 2 KEYNOTE-180 Study | 2019 | 61 |
| 6 | 2022 | 48 | |
| 7 | 2023 | 44 | |
| 8 | 2005 | 35 | |
| 9 | 2021 | 31 | |
| 10 | 2016 | 30 | |
| 11 | 2021 | 24 | |
| 12 | 2024 | 21 | |
| 13 | 2003 | 20 | |
| 14 | 2011 | 18 | |
| 15 | 2011 | 16 | |
| 16 | 2020 | 14 | |
| 17 | 2020 | 11 | |
| 18 | 2011 | 9 | |
| 19 | 2011 | 8 | |
| 20 | 2025 | 7 |
About S-B. Kim
S-B. Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Otorhinolaryngology and Surgery, having authored 53 papers that have together received 857 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (16 papers), Advanced Breast Cancer Therapies (15 papers), Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (5 papers), Esophageal Cancer Research and Treatment (4 papers), Head and Neck Cancer Studies (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Oncology (301 citations), Cancer Research (135 citations), Pulmonary and Respiratory Medicine (259 citations), Otorhinolaryngology (28 citations) and Radiology, Nuclear Medicine and Imaging (80 citations). S-B. Kim has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Hee Jung Shin, Kyung Hae Jung, Seong Hee Ahn, Seock‐Ah Im, Takashi Kojima, Pooja Bhagia, Peter C. Enzinger, Jillian M. Cathcart, Y.H. Park and Giuseppe Curigliano. Their work appears in journals such as Annals of Oncology, ESMO Open, Cancer Research, Diseases of Aquatic Organisms and British Journal of Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.